Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis.
Bonovas S, Minozzi S, Lytras T, González-Lorenzo M, Pecoraro V, Colombo S, Polloni I, Moja L, Cinquini M, Marino V, Goletti D, Matucci A, Tocci G, Milano GM, Scarpa R, Cantini F. Bonovas S, et al. Among authors: cantini f. Expert Opin Drug Saf. 2016 Dec;15(sup1):35-54. doi: 10.1080/14740338.2016.1238458. Expert Opin Drug Saf. 2016. PMID: 27924644 Review.
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy.
Olivieri I, de Portu S, Salvarani C, Cauli A, Lubrano E, Spadaro A, Cantini F, Cutro MS, Mathieu A, Matucci-Cerinic M, Pappone N, Punzi L, Scarpa R, Mantovani LG; PACE working group. Olivieri I, et al. Among authors: cantini f. Rheumatology (Oxford). 2008 Nov;47(11):1664-70. doi: 10.1093/rheumatology/ken320. Epub 2008 Aug 24. Rheumatology (Oxford). 2008. PMID: 18725374 Free PMC article.
Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor alpha therapy: is there a need for more comprehensive screening procedures?
Nannini C, Cantini F, Niccoli L, Cassarà E, Salvarani C, Olivieri I, Lally EV. Nannini C, et al. Among authors: cantini f. Arthritis Rheum. 2009 Jun 15;61(6):801-12. doi: 10.1002/art.24506. Arthritis Rheum. 2009. PMID: 19479708 Free article. Review.
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study.
Spadaro A, Punzi L, Marchesoni A, Lubrano E, Mathieu A, Cantini F, Olivieri I, Salvarani C, Scarpa R, Scrivo R, Ramonda R, Porru G, D'Angelo S, Catanoso M, Atteno M, Valesini G. Spadaro A, et al. Among authors: cantini f. Rheumatology (Oxford). 2010 Jun;49(6):1107-11. doi: 10.1093/rheumatology/keq008. Epub 2010 Mar 11. Rheumatology (Oxford). 2010. PMID: 20223813
Psoriatic arthritis: a systematic review.
Cantini F, Niccoli L, Nannini C, Kaloudi O, Bertoni M, Cassarà E. Cantini F, et al. Int J Rheum Dis. 2010 Oct;13(4):300-17. doi: 10.1111/j.1756-185X.2010.01540.x. Int J Rheum Dis. 2010. PMID: 21199465 Review.
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology.
Salvarani C, Pipitone N, Marchesoni A, Cantini F, Cauli A, Lubrano E, Punzi L, Scarpa R, Spadaro A, Matucci-Cerinic M, Olivieri I; Italian Society for Rheumatology. Salvarani C, et al. Among authors: cantini f. Clin Exp Rheumatol. 2011 May-Jun;29(3 Suppl 66):S28-41. Epub 2011 Jul 26. Clin Exp Rheumatol. 2011. PMID: 21906425 Review.
309 results